Literature DB >> 15608689

Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer.

Jean-Paul Delgado1, Alexandre Parouchev, Jean-Etienne Allain, Gaëlle Pennarun, Laurent R Gauthier, Anne-Marie Dutrillaux, Bernard Dutrillaux, James Di Santo, Frédérique Capron, François D Boussin, Anne Weber.   

Abstract

Hepatoblasts are bipotent progenitors of both hepatocytes and cholangiocytes. The lack of stable in vitro culture systems for such cells makes it necessary to generate liver progenitor cell lines by means of immortalization. In this study, we describe the long-term behaviour of a clone of simian foetal hepatic progenitor cells immortalized by Simian virus 40 (SV40) large T-antigen (T-Ag) flanked by loxP sites. Immortalization was associated with the re-expression of telomerase activity, which decreased at late passages (population doubling 120) after more than a year in culture. This decrease was concomitant to telomere shortening and karyotypic instability. However, the chromosomes carrying the p53 gene remained intact and long-term immortalized progenitor cells maintained contact inhibition and proliferative properties. They also displayed the features of a normal bipotent phenotype. We constructed a retroviral vector expressing an inducible Cre recombinase and transferred it into the immortalized progenitors. Activation of the Cre recombinase by 4-hydroxy-tamoxifen induced SV40 T-Ag excision, leading to the death of cells expressing Cre recombinase. Immortalized progenitors at late passages stopped growing and eventually disappeared after transplantation into the livers of immunocompromised mice. These cells provide a novel model to study hepatic differentiation and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608689     DOI: 10.1038/sj.onc.1208089

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Differentiation of immortalized human precartilaginous stem cells into nucleus pulposus-like cells.

Authors:  Qiong Wang; Xiaofeng Gu; Li Cheng; Junfang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  miRNA-324, a potential therapeutic target for paracetamol-induced liver injury.

Authors:  Hong Min Wu; Sang Geon Kim
Journal:  Stem Cell Investig       Date:  2016-10-25

3.  In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins.

Authors:  Hua Liu; Yonghak Kim; Saul Sharkis; Luigi Marchionni; Yoon-Young Jang
Journal:  Sci Transl Med       Date:  2011-05-11       Impact factor: 17.956

Review 4.  The supply chain of human pancreatic β cell lines.

Authors:  Raphael Scharfmann; Willem Staels; Olivier Albagli
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

5.  Immortalization of human precartilaginous stem cells by transfecting SV40Tag.

Authors:  Junfang Wang; Huang Fang; Renyun Xia; Anming Chen; Hao Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

6.  Development of a conditionally immortalized human pancreatic β cell line.

Authors:  Raphaël Scharfmann; Severine Pechberty; Yasmine Hazhouz; Manon von Bülow; Emilie Bricout-Neveu; Maud Grenier-Godard; Fanny Guez; Latif Rachdi; Matthias Lohmann; Paul Czernichow; Philippe Ravassard
Journal:  J Clin Invest       Date:  2014-03-25       Impact factor: 14.808

7.  Establishment and characterisation of a novel bovine SV40 large T-antigen-transduced foetal hepatocyte-derived cell line.

Authors:  Alexander Gleich; Bastian Kaiser; Julia Schumann; Herbert Fuhrmann
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-12       Impact factor: 2.416

8.  Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.

Authors:  Yong Soon Chun; Kyunghee Byun; Bonghee Lee
Journal:  Anat Cell Biol       Date:  2011-12-30

Review 9.  Cellular Transplantation for Liver Diseases.

Authors:  Elizabeth Jameson
Journal:  Gastroenterology Res       Date:  2008-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.